BA
TNDM icon

Bridgewater Associates’s Tandem Diabetes Care TNDM Stock Holding History

Bridgewater Associates’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,378
Closed -$266K – 797
2024
Q4 		$266K Sell
7,378
-18,257
-71% -$618K ﹤0.01% 642
2024
Q3 		$1.09M Buy
25,635
+13,299
+108% +$564K 0.01% 587
2024
Q2 		$497K Sell
12,336
-47,264
-79% -$1.97M ﹤0.01% 754
2024
Q1 		$2.11M Sell
59,600
-8,784
-13% -$235K 0.01% 492
2023
Q4 		$2.02M Sell
68,384
-9,175
-12% -$190K 0.01% 512
2023
Q3 		$1.61M Buy
77,559
+8,010
+12% +$220K 0.01% 532
2023
Q2 		$1.71M Sell
69,549
-9,435
-12% -$304K 0.01% 491
2023
Q1 		$3.21M Buy
78,984
+3,137
+4% +$130K 0.02% 381
2022
Q4 		$3.41M Sell
75,847
-25,896
-25% -$1.17M 0.02% 437
2022
Q3 		$4.87M Buy
101,743
+249
+0.2% +$13.7K 0.02% 384
2022
Q2 		$6.01M Buy
101,494
+9,244
+10% +$759K 0.03% 447
2022
Q1 		$10.7M Buy
92,250
+22,390
+32% +$2.61M 0.04% 288
2021
Q4 		$10.5M Buy
69,860
+12,252
+21% +$1.65M 0.06% 185
2021
Q3 		$6.88M Sell
57,608
-4,997
-8% -$551K 0.04% 249
2021
Q2 		$6.1M Buy
+62,605
New +$5.58M 0.04% 295

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgewater Associates's TNDM Position: Q1 2025 in Review

Bridgewater Associates sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 7,378 shares — an estimated $266K sold.

Bridgewater Associates first reported a position in TNDM in Q2 2021 and held it in 15 quarters. The position peaked at $10.7M in Q1 2022. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Bridgewater Associates reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 7,378 Tandem Diabetes Care shares in Q1 2025, an estimated $266K.
  • Bridgewater Associates first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 15 quarters.
  • Bridgewater Associates's Tandem Diabetes Care position peaked at $10.7M in Q1 2022.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.